Gerard Aurigemma to Double-Blind Method
This is a "connection" page, showing publications Gerard Aurigemma has written about Double-Blind Method.
Connection Strength
0.069
-
Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahl?f B, Roman MJ, K?ber L, Wachtell K, Devereux RB. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens. 2013 Oct; 31(10):2060-8.
Score: 0.024
-
Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourci?re Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007 Jun 23; 369(9579):2079-87.
Score: 0.016
-
Janardhanan R, Daley WL, Naqvi TZ, Mulvagh SL, Aurigemma G, Zile M, Arnold JM, Artis E, Purkayastha D, Thomas JD, Solomon SD. Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J. 2006 Aug; 152(2):246-52.
Score: 0.015
-
Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol. 2000 Sep 15; 86(6):669-74.
Score: 0.010
-
Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B, Fung HL. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation. 1988 Jun; 77(6):1376-84.
Score: 0.004